Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

60 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 4, 2025Nov 4 9:14 PMSANDRA CALVIN
Proposed Sale
67,115$36.00$2.4M—

View →

Oct 31, 2025Oct 31 8:05 PMCoughlin Timothy
Proposed Sale
18,000$34.98$629.7K—

View →

Oct 31, 2025Oct 31 6:51 PMHeerma Peter
Proposed Sale
5,591$35.00$195.7K—

View →

Oct 29, 2025Oct 29 8:26 PMDube Eric M
Proposed Sale
27,128$30.12$817.0K—

View →

Oct 28, 2025Oct 28 8:57 PMDube Eric M
Proposed Sale
92,872$30.38$2.8M—

View →

Oct 28, 2025Oct 28 6:08 PMHeerma Peter
Proposed Sale
2,662$30.00$79.9K—

View →

Sep 22, 2025Sep 22 8:02 PMELIZABETH REED
Proposed Sale
10,000$25.00$250.0K—

View →

May 5, 2025May 5 11:45 PMChristopher Cline
Proposed Sale
1,784$21.05$37.6K—

View →

May 5, 2025May 5 11:41 PMPeter Heerma
Proposed Sale
1,771$21.05$37.3K—

View →

May 5, 2025May 5 3:32 PMREED ELIZABETH E
Proposed Sale
4,920$21.05$103.6K—

View →

May 5, 2025May 5 3:20 PMDube Eric M
Proposed Sale
18,924$21.05$398.4K—

View →

May 5, 2025May 5 2:08 PMROTE WILLIAM E.
Proposed Sale
3,198$21.05$67.3K—

View →

Apr 11, 2025Apr 11 11:03 PMChristopher Cline
Proposed Sale
48$13.14$631—

View →

Feb 12, 2025Feb 13 12:47 AMPeter Heerma
Proposed Sale
2,568$23.53$60.4K—

View →

Feb 12, 2025Feb 13 12:46 AMJula Inrig
Proposed Sale
2,568$23.53$60.4K—

View →

Feb 12, 2025Feb 12 4:03 PMROTE WILLIAM E.
Proposed Sale
5,200$23.53$122.4K—

View →

Feb 12, 2025Feb 12 2:52 PMREED ELIZABETH E
Proposed Sale
8,000$23.53$188.2K—

View →

Feb 11, 2025Feb 11 9:08 PMSANDRA CALVIN
Proposed Sale
54,244$25.00$1.4M—

View →

Feb 11, 2025Feb 11 9:04 PMPETER HEERMA
Proposed Sale
3,074$25.00$76.8K—

View →

Feb 11, 2025Feb 11 4:56 PMDube Eric M
Proposed Sale
11,375$24.04$273.5K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 16, 2026Sep 18 1:35 AMWilliam E. RoteChief Research Officer
Option Exercise
112,850$26.880(D)

View →

Sep 15, 2026Sep 18 1:35 AMWilliam E. RoteChief Research Officer
Option Exercise
78,650$25.25350(D)

View →

Sep 17, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
8,282$22.4044,837(D)

View →

Sep 16, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
172,717$26.88500(D)

View →

Sep 15, 2026Sep 18 1:35 AMPeter HeermaEVP, CHIEF COMMERCIAL OFFICER
Option Exercise
77,190$26.8828,474(D)

View →

Sep 15, 2026Sep 18 1:33 AMJula InrigEVP, Head of R&D & CMO
Option Exercise
32,395$8.9343,605(D)

View →

Sep 15, 2026Sep 18 1:32 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
37,500$15.460(D)

View →

Sep 17, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
108,493$23.340(D)

View →

Sep 16, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
195,841$23.34108,493(D)

View →

Sep 15, 2026Sep 18 1:31 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
95,666$23.34304,334(D)

View →

Sep 15, 2026Sep 18 1:30 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Option Exercise
20,000$17.440(D)

View →

Sep 15, 2026Sep 18 1:29 AMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
5,375$27.5017,875(D)

View →

Sep 10, 2026Sep 11 8:05 PMMeckler Jeffrey ADirector
Option Exercise
20,000$26.520(D)

View →

Aug 18, 2026Aug 19 8:05 PMLYONS GARY ADirector
Option Exercise
5,000$17.440(D)

View →

Aug 17, 2026Aug 19 8:05 PMLYONS GARY ADirector
Option Exercise
5,000$17.445,000(D)

View →

Jun 12, 2026Jun 16 8:46 PMTimothy CoughlinDirector
Option Exercise
10,000$26.520(D)

View →

Jun 12, 2026Jun 16 8:42 PMRoy D. BaynesDirector
Option Exercise
4,500$21.380(D)

View →

May 19, 2026May 21 9:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

Page 1 of 4

Next →